SOLV – solventum corporation (US:NASDAQ)

News

Solventum (NYSE:SOLV) was given a new $105.00 price target on by analysts at Stifel Nicolaus.
Solventum Completes Acquisition of Acera Surgical
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy
Solventum (NYSE:SOLV) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com